Estradiol/norethisterone acetate explained
Estradiol/norethisterone acetate (E2/NETA), sold under the brand name Activella among others, is a combination of estradiol (E2) and norethisterone acetate (NETA) which is used in the treatment of vasomotor symptoms, vulvar and vaginal atrophy, and osteoporosis[1] associated with menopause.[2] Activella specifically is marketed by Novo Nordisk and is supplied as film-coated tablets containing 1 mg estradiol and 0.5 mg norethisterone acetate. CombiPatch is a combination of estradiol and NETA provided as a transdermal patch.
See also
Notes and References
- Morabito N, Crisafulli A, Vergara C, Gaudio A, Lasco A, Frisina N, D'Anna R, Corrado F, Pizzoleo MA, Cincotta M, Altavilla D, Ientile R, Squadrito F . 6 . Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study . Journal of Bone and Mineral Research . 17 . 10 . 1904–12 . October 2002 . 12369794 . 10.1359/jbmr.2002.17.10.1904 . 29312298 . free .
- Web site: CombiPatch (estradiol/norethindrone acetate transdermal system) Prescribing Information . Noven Pharmaceuticals, Inc. . U.S. Food and Drug Administration .